Advertisement
Advertisement
BLCO
Bausch + Lomb Corporation
16.01
USDSponsored
+0.30
+1.93%
Mar 25, 16:00 UTC -4
Closed
After-Market
16.01
0.00
-0.02%
BLCO Earnings Reports
Positive Surprise Ratio
BLCO beat 11 of 15 last estimates.
73%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Bausch + Lomb Corporation earnings per share and revenue
On Feb 18, 2026, BLCO reported earnings of 0.32 USD per share (EPS) for Q4 25, missing the estimate of 0.35 USD, resulting in a -10.76% surprise. Revenue reached 1.41 billion, compared to an expected 1.41 billion, with a -0.28% difference. The market reacted with a -0.34% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
Sonida Senior Living, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$1.25
Actual
-$1.29
Surprise
-2.41%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Bausch + Lomb Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Bausch + Lomb Corporation reported EPS of $0.32, missing estimates by -10.76%, and revenue of $1.41B, -0.28% below expectations.
How did the market react to Bausch + Lomb Corporation's Q4 2025 earnings?
The stock price moved down -0.34%, changed from $17.73 before the earnings release to $17.67 the day after.
When is Bausch + Lomb Corporation expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Bausch + Lomb Corporation's next earnings report?
Based on --
analysts, Bausch + Lomb Corporation is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement